266 results
Page 4 of 14
8-K
EX-99.2
8fsiski3
2 Mar 20
Amicus Therapeutics Announces Full-Year 2019 Financial Results and 2020 Corporate Updates
7:03am
8-K
EX-99.1
7tiucq 7p0q0
12 Feb 20
Other Events
5:20pm
8-K
EX-99.2
tl7p1b9
13 Jan 20
Amicus Therapeutics Provides Full-Year 2020 Strategic Outlook and Financial Guidance
7:00am
8-K
EX-99.2
cpe5dyqhpa30x7mer
14 Nov 19
Amicus Therapeutics Announces Third Quarter 2019 Financial Results and Corporate Updates
5:09pm
8-K
EX-99.3
thtf6 xl0
14 Nov 19
Amicus Therapeutics Announces Third Quarter 2019 Financial Results and Corporate Updates
5:09pm
8-K
EX-99.1
7vxqv5d818n8u1prapp5
24 Oct 19
Amicus Announces Additional Positive Interim Clinical Data for CLN6 Batten Disease Gene Therapy at 48th Annual Meeting of the Child Neurology Society
7:00am
8-K
EX-99.2
7jo5 zbvq
10 Oct 19
Amicus Therapeutics Announces Preliminary Third Quarter 2019 Revenue and Financial Outlook at 2019 Analyst Day
7:31am
8-K
EX-99.1
xhjn54nk 3og
2 Oct 19
Other Events
7:56am
8-K
EX-99.2
oam0l2 n1eou
2 Oct 19
Other Events
7:56am
8-K
EX-99.1
3ijh 40b4doean
8 Aug 19
Amicus Therapeutics Announces Second Quarter 2019 Financial Results and Corporate Updates
7:07am
8-K
EX-99.2
yfe 76qbx
1 Aug 19
Amicus Announces Positive Interim Clinical Data for AAV Gene Therapy in Children with CLN6 Batten Disease
6:10am
8-K
EX-99.1
putdh4b4352
1 Aug 19
Amicus Announces Positive Interim Clinical Data for AAV Gene Therapy in Children with CLN6 Batten Disease
6:10am
8-K/A
EX-99.1
ohsoy2slkdc
8 Jul 19
Other Events
9:18pm
8-K
EX-99.1
foy18wx6is1x1zx3sdp
8 Jul 19
Other Events
4:36pm
424B5
vcmkpxetf67g
31 May 19
Prospectus supplement for primary offering
5:14pm
424B5
fgz qc190ih
30 May 19
Prospectus supplement for primary offering
12:00am
8-K
EX-99.2
572opnczrxjut
29 May 19
Entry into a Material Definitive Agreement
6:32am